EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Invasive meningococcal disease in Norway in the two decades before the COVID-19 pandemic

Ola Brønstad Brynildsrud, Sara Viksmoen Watle, Kristian Alfsnes, Dominique A Caugant

International Journal of Infectious Diseases · 2023

DOI: 10.1016/j.ijid.2023.04.005 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Infectious Diseases, 2023. Verfasst von Ola Brønstad Brynildsrud und 3 weiteren Autor:innen. Beteiligte Einrichtung: Division for Infection Control, Norwegian Institute of Public Health, Oslo, Norway. Hauptthemen laut MEDLINE: COVID-19, Meningococcal Infections, Neisseria meningitidis, Meningococcal Vaccines. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVES: Disease caused by the bacterium Neisseria meningitidis remains a worldwide public health challenge, despite the steadily decreasing incidence in Western countries. The objective of this study was to explore the epidemiology of invasive meningococcal disease in Norway over the last two decades. DESIGN: All isolates sent to the National Reference Laboratory from patients with invasive meningococcal disease between the years 2000 and 2019 were analyzed using whole genome sequencing (total: 625). RESULTS: A five-fold decrease in case numbers occurred over this period, and the situation has gone from being dominated by serogroup B to one where serogroups Y and W are more prevalent. Concurrently, the mean age at infection has increased from 18 to 33 years. Among the 350 serogroup B isolates, 87% were an exact match or cross-reactive with one or both the currently available serogroup B vaccines, but the proportion decreased in the past decade. Core genome analyses revealed a high variation in the number of allelic differences accumulated in epidemiologically linked isolates to the point that near-identical isolates were found several years apart. CONCLUSION: Allelic distance is an imprecise metric for the degree of epidemiologic linkage between isolates in N. meningitidis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19Meningococcal InfectionsNeisseria meningitidisMeningococcal VaccinesHumansAdolescentYoung AdultAdultPandemicsNorwaySerogroup

Stichwörter der Autor:innen

Disease outbreaksGenomic epidemiologyMeningitisNeisseria meningitidisTransmissionVaccine antigens

Substanzen

Meningococcal Vaccines

Autor:innen und Institutionen

  • Division for Infection Control, Norwegian Institute of Public Health, Oslo, Norway.
  • Division for Infection Control, Norwegian Institute of Public Health, Oslo, Norway; Department of Community Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway.
  • Division for Infection Control, Norwegian Institute of Public Health, Oslo, Norway; Department of Community Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway. Electronic address: dominique.caugant@fhi.no.

Zitieren

APA

Brynildsrud, O. B., Watle, S. V., Alfsnes, K., & Caugant, D. A. (2023). Invasive meningococcal disease in Norway in the two decades before the COVID-19 pandemic. International Journal of Infectious Diseases. https://doi.org/10.1016/j.ijid.2023.04.005

Vancouver

Brynildsrud OB, Watle SV, Alfsnes K, Caugant DA. Invasive meningococcal disease in Norway in the two decades before the COVID-19 pandemic. International Journal of Infectious Diseases. 2023. doi:10.1016/j.ijid.2023.04.005

BibTeX
@article{Brynildsrud2023,
  author = {Brynildsrud, Ola Brønstad and Watle, Sara Viksmoen and Alfsnes, Kristian and Caugant, Dominique A},
  title = {Invasive meningococcal disease in Norway in the two decades before the COVID-19 pandemic},
  journal = {International Journal of Infectious Diseases},
  year = {2023},
  doi = {10.1016/j.ijid.2023.04.005}
}
Kostenlos starten →